Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 188 | 123 | 0 | 0 | 0 |
| Cost of Goods | 146 | 86 | N/A | N/A | N/A |
| Gross Profit | 42 | 38 | N/A | N/A | N/A |
| Operating Expenses | 4,918 | 5,610 | 7,886 | 7,134 | 5,381 |
| Operating Income | -4,730 | -5,487 | -7,886 | -7,134 | -5,381 |
| Interest Expense | 229 | 144 | 159 | 168 | 164 |
| Other Income | 6 | -3 | -11 | 3 | -12 |
| Pre-tax Income | -4,954 | -5,633 | -8,056 | -7,298 | -5,557 |
| Net Income Continuous | -4,954 | -5,633 | -8,056 | -7,298 | -5,557 |
| Net Income | $-4,954 | $-5,633 | $-8,056 | $-7,298 | $-5,557 |
| EPS Basic Total Ops | -0.13 | -0.15 | -0.22 | -0.26 | -0.20 |
| EPS Basic Continuous Ops | -0.13 | -0.15 | -0.22 | -0.26 | -0.20 |
| EPS Diluted Total Ops | -0.13 | -0.15 | -0.22 | -0.26 | -0.20 |
| EPS Diluted Continuous Ops | -0.13 | -0.15 | -0.22 | -0.26 | -0.20 |
| EBITDA(a) | $-4,620 | $-5,367 | $-7,749 | $-6,996 | $-5,255 |